Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer
- PMID: 22102972
- PMCID: PMC3218126
- DOI: 10.3393/jksc.2011.27.5.231
Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer
Abstract
Purpose: Phosphatase of regenerating liver-3 (PRL-3) has been associated with metastasis promotion. However, clinical applications of this association have not yet been clearly demonstrated. In this study, we evaluated the relation of PRL-3 mRNA level in primary colorectal cancer to the corresponding stage and to other clinicopathologic factors.
Methods: Two hundred forty-five patients with histologically-proven colorectal cancer underwent surgery between January 2004 and December 2006. RNA was extracted and cDNA was prepared by using reverse transcription. Quantification of PRL-3 was done using a real-time polymerase chain reaction.
Results: Eighty-six cases with well-preserved specimens were enrolled: 53 males and 33 females. The mean age was 63.4 years. According to tumour node metastasis (TNM) stage of the American Joint Committee on Cancer (AJCC), stage I was 11 cases, stage II was 38 cases, stage III was 23 cases, and stage IV was 14 cases. Among stage IV cases, one case was combined with liver and lung metastases, and one case was combined with liver metastases and peritoneal dissemination. The remaining stage IV patients were combined with only liver metastases. There was a significant correlation in PRL-3 mRNA expression between primary colorectal cancer and corresponding tumor stage. PRL-3 mRNA expression was increased in the liver metastases cases. Lymphatic and vascular invasion were significantly related with PRL-3 mRNA levels.
Conclusion: Advanced stage prediction may be obtained by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Especially, the risk of liver metastases may be predicted by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Further study is required to confirm these preliminary results.
Keywords: Colorectal neoplasms; Neoplasm Metastasis; PTP4A3 protein, human; Real-time polymerase chain reaction.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer.Clin Cancer Res. 2006 Jan 1;12(1):29-33. doi: 10.1158/1078-0432.CCR-05-1275. Clin Cancer Res. 2006. PMID: 16397020
-
[Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].Zhonghua Wei Chang Wai Ke Za Zhi. 2005 May;8(3):237-40. Zhonghua Wei Chang Wai Ke Za Zhi. 2005. PMID: 16167237 Chinese.
-
High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.Clin Cancer Res. 2004 Nov 1;10(21):7318-28. doi: 10.1158/1078-0432.CCR-04-0485. Clin Cancer Res. 2004. PMID: 15534108
-
[Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Sep;11(5):487-91. Zhonghua Wei Chang Wai Ke Za Zhi. 2008. PMID: 18803057 Chinese.
-
[Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].Gan To Kagaku Ryoho. 2009 Nov;36(12):2232-5. Gan To Kagaku Ryoho. 2009. PMID: 20037380 Review. Japanese.
Cited by
-
Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion.PLoS One. 2013 May 17;8(5):e64309. doi: 10.1371/journal.pone.0064309. Print 2013. PLoS One. 2013. PMID: 23691193 Free PMC article.
-
Biomarkers for predicting future metastasis of human gastrointestinal tumors.Cell Mol Life Sci. 2013 Oct;70(19):3631-56. doi: 10.1007/s00018-013-1266-8. Epub 2013 Jan 31. Cell Mol Life Sci. 2013. PMID: 23370778 Free PMC article. Review.
-
Colorectal liver metastasis: molecular mechanism and interventional therapy.Signal Transduct Target Ther. 2022 Mar 4;7(1):70. doi: 10.1038/s41392-022-00922-2. Signal Transduct Target Ther. 2022. PMID: 35246503 Free PMC article. Review.
References
-
- Zhang ZY, Zhou B, Xie L. Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharmacol Ther. 2002;93:307–317. - PubMed
-
- Hunter T. Signaling: 2000 and beyond. Cell. 2000;100:113–127. - PubMed
-
- Li L, Dixon JE. Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin Immunol. 2000;12:75–84. - PubMed
-
- Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997;9:193–204. - PubMed
-
- Van Vactor D, O'Reilly AM, Neel BG. Genetic analysis of protein tyrosine phosphatases. Curr Opin Genet Dev. 1998;8:112–126. - PubMed
LinkOut - more resources
Full Text Sources